Godavari Drugs

Godavari Drugs EBITDA per Employee

EBITDA per Employee of Godavari Drugs (530317.BO) as of Oct 22, 2026.

EBITDA per Employee

-INR

Last updated:

EBITDA per Employee of Godavari Drugs is 2026 - INR. EBITDA per Employee of Godavari Drugs was 2025 - INR. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Godavari Drugs Stock analysis

What does Godavari Drugs do? Godavari Drugs Ltd, based in Secunderabad, Telangana, manufactures active pharmaceutical ingredients (APIs) and intermediates for the global life science industry. The company operates facilities in Nanded, Maharashtra, producing APIs such as Ciprofloxacin HCl and Mefenamic Acid, along with intermediates like A D Lactone and 6 Mercaptopurine. It partners with multinational firms through contract manufacturing and holds active loan licenses for API production. Godavari Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Godavari Drugs stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Godavari Drugs since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Godavari Drugs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Godavari Drugs

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Godavari Drugs